Concepedia

David James VanderWeele

DJ

Statistics

Publications

30

Citations

1.7K

H-Index

21

Active since

2002

Affiliations

University of Chicago(Current)

National Cancer Institute

Northwestern University

Center for Cancer Research

Johns Hopkins University

David James VanderWeele is an author at University of Chicago specializing in oncology, medicine, and prostate cancer.

ORCID

Publications per year

2002–2025

30

Publications

30

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Fatima Karzai, David James VanderWeele, Ravi A. Madan et al. · Journal for ImmunoTherapy of Cancer · 2018 · 312 citations · Full text

, , +17

Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells

Esther Hulleman, Karin M. Kazemier, Amy de Haar-Holleman et al. · Blood · 2008 · 213 citations · Full text

, , +12

Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.

Charles M. Rudin, Zejia Yang, Lisa M. Schumaker et al. · PubMed · 2003 · 174 citations

, , +17

Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin

David James VanderWeele, Rixin Zhou, Charles M. Rudin · Molecular Cancer Therapeutics · 2004 · 116 citations

, , +17

Accelerating precision medicine in metastatic prostate cancer

Joaquı́n Mateo, Rana R. McKay, Wassim Abida et al. · Nature Cancer · 2020 · 77 citations · Full text

, , +14

1–5 of 30